{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Short+Acting+Beta+2+Agonist", "query": { "intervention": "Short Acting Beta 2 Agonist" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-24T21:57:12.773Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06422689", "title": "Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Albuterol and budesonide inhalation aerosol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "130 Years", "sex": "ALL", "summary": "18 Years to 130 Years" }, "enrollment_count": 1511, "start_date": "2024-05-10", "completion_date": "2027-02-03", "has_results": false, "last_update_posted_date": "2026-07-16", "last_synced_at": "2026-09-24T21:57:12.773Z", "location_count": 11, "location_summary": "North Hollywood, California • Walnut Creek, California • Louisville, Kentucky + 8 more", "locations": [ { "city": "North Hollywood", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT06422689" }, { "nct_id": "NCT02969408", "title": "A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Albuterol Sulfate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 397, "start_date": "2017-02-13", "completion_date": "2018-02-02", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-09-24T21:57:12.773Z", "location_count": 44, "location_summary": "Litchfield Park, Arizona • Bakersfield, California • Los Angeles, California + 37 more", "locations": [ { "city": "Litchfield Park", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Riverside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02969408" }, { "nct_id": "NCT00677807", "title": "Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "COPD" ], "interventions": [ { "name": "Indacaterol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 415, "start_date": "2008-05", "completion_date": "2009-03", "has_results": true, "last_update_posted_date": "2011-08-22", "last_synced_at": "2026-09-24T21:57:12.773Z", "location_count": 93, "location_summary": "Homewood, Alabama • Jasper, Alabama • Phoenix, Arizona + 83 more", "locations": [ { "city": "Homewood", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Pine Bluff", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00677807" }, { "nct_id": "NCT01079130", "title": "Efficacy and Safety of Different Doses of Indacaterol", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Indacaterol", "type": "DRUG" }, { "name": "Salmeterol", "type": "DRUG" }, { "name": "Placebo to Indacaterol", "type": "DRUG" }, { "name": "Placebo to Salmeterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 511, "start_date": "2010-02", "completion_date": null, "has_results": true, "last_update_posted_date": "2011-08-19", "last_synced_at": "2026-09-24T21:57:12.773Z", "location_count": 71, "location_summary": "Glendale, Arizona • Scottsdale, Arizona • Encinitas, California + 64 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Encinitas", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01079130" }, { "nct_id": "NCT03256695", "title": "Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Albuterol sulfate (ABS)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 405, "start_date": "2017-09-28", "completion_date": "2018-04-17", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-09-24T21:57:12.773Z", "location_count": 40, "location_summary": "Andalusia, Alabama • Anniston, Alabama • Mobile, Alabama + 34 more", "locations": [ { "city": "Andalusia", "state": "Alabama" }, { "city": "Anniston", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Gold River", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03256695" }, { "nct_id": "NCT01397162", "title": "Dose Finding Study on BI54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat® Inhaler in Asthmatic Patients Inadequately Controlled on Short-acting-beta-agonist (SABA) Therapy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone propionate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "BI 54903", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "12 Years to 65 Years" }, "enrollment_count": 29, "start_date": "2011-07-21", "completion_date": "2011-12-23", "has_results": true, "last_update_posted_date": "2022-06-23", "last_synced_at": "2026-09-24T21:57:12.773Z", "location_count": 41, "location_summary": "Fountain Valley, California • Huntington Beach, California • Long Beach, California + 36 more", "locations": [ { "city": "Fountain Valley", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Palmdale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01397162" }, { "nct_id": "NCT02889809", "title": "Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a Year", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone furoate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Montelukast", "type": "DRUG" }, { "name": "Short Acting Beta 2 Agonist", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "9 Years", "sex": "ALL", "summary": "5 Years to 9 Years" }, "enrollment_count": 477, "start_date": "2017-07-10", "completion_date": "2021-06-04", "has_results": true, "last_update_posted_date": "2024-01-17", "last_synced_at": "2026-09-24T21:57:12.773Z", "location_count": 18, "location_summary": "Little Rock, Arkansas • Huntington Beach, California • Homestead, Florida + 12 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Homestead", "state": "Florida" }, { "city": "Loxahatchee Groves", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02889809" }, { "nct_id": "NCT03546907", "title": "Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "SAR440340", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Any Inhaled Corticosteroids as prescribed by treating physician as standard of care", "type": "DRUG" }, { "name": "Any Long Acting Beta Agonist as prescribed by treating physician as standard of care", "type": "DRUG" }, { "name": "Any Long Acting Muscarinic Agonist as prescribed by treating physician as standard of care", "type": "DRUG" }, { "name": "Any short-acting β agonist as prescribed by treating physician as standard of care", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "40 Years to 75 Years" }, "enrollment_count": 343, "start_date": "2018-07-16", "completion_date": "2020-02-21", "has_results": true, "last_update_posted_date": "2022-11-22", "last_synced_at": "2026-09-24T21:57:12.773Z", "location_count": 16, "location_summary": "Los Angeles, California • Riverside, California • Rolling Hills Estates, California + 13 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "Rolling Hills Estates", "state": "California" }, { "city": "Westminster", "state": "California" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03546907" }, { "nct_id": "NCT01147744", "title": "Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone Propionate 100mcg via ACCUHALER/DISKUS", "type": "DRUG" }, { "name": "GSK2190915 100mg", "type": "DRUG" }, { "name": "GSK2190915 10mg", "type": "DRUG" }, { "name": "GSK2190915 300mg", "type": "DRUG" }, { "name": "GSK2190915 30mg", "type": "DRUG" }, { "name": "Montelukast 10mg", "type": "DRUG" }, { "name": "Placebo GSK2190915 one tablet", "type": "DRUG" }, { "name": "Placebo montelukast", "type": "DRUG" }, { "name": "Placebo fluticasone propionate via ACCUHALER/DISKUS", "type": "DRUG" }, { "name": "Placebo GSK2190915 two tablets", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "FEMALE", "summary": "12 Years and older · Female only" }, "enrollment_count": 700, "start_date": "2010-06-28", "completion_date": "2011-10-06", "has_results": true, "last_update_posted_date": "2017-10-02", "last_synced_at": "2026-09-24T21:57:12.773Z", "location_count": 22, "location_summary": "Birmingham, Alabama • Huntington Beach, California • Newport Beach, California + 19 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Tallahassee", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01147744" }, { "nct_id": "NCT02401074", "title": "Airway Temperature", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Segmental Bronchoprovocation with Allergen (SBP-Ag)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Lu Yuan Lee", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 0, "start_date": "2018-11-08", "completion_date": "2020-06", "has_results": false, "last_update_posted_date": "2020-12-09", "last_synced_at": "2026-09-24T21:57:12.773Z", "location_count": 1, "location_summary": "Lexington, Kentucky", "locations": [ { "city": "Lexington", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT02401074" } ] }